Biora Therapeutics News

Biora Therapeutics | ARS: Annual Report to Security Holders

Apr 24 16:15 ET

Biora Therapeutics | DEFA14A: Others

Apr 24 16:09 ET

Biora Therapeutics | DEF 14A: Definitive information statements

Apr 24 16:06 ET

Biora Therapeutics | EFFECT: Others

Apr 18 06:06 ET

Biora Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 12 16:34 ET

Biora Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Apr 8 16:13 ET

Biora Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jeffrey A. Ferrell(49.9%),Athyrium Funds GP Holdings LLC(49.9%), etc.

Apr 2 20:46 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:53 ET

Biora Therapeutics | 8-K: Current report

Apr 2 16:51 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:48 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:46 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:45 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:41 ET

Biora Therapeutics | 424B5: Prospectus

Apr 2 16:41 ET

Biora Therapeutics | 10-K: Annual report

Apr 1 16:49 ET

Biora Therapeutics | 424B5: Prospectus

Apr 1 16:05 ET

Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results

Mar 26 16:16 ET

Biora Therapeutics | SCHEDULE 13G: Others

Mar 20 18:33 ET

Biora Therapeutics | 8-K: Current report

Mar 11 08:11 ET

Biora Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MOHANTY ADITYA P.

Feb 15 16:09 ET